Supreme Court’s Caraco ruling signals need for FDA fix
The US Supreme Court has once again reversed the Federal Circuit in a case some hope may result in the Food and Drug Administration clarifying its guidelines on use codes filed with new drug applications
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
